StanleyJChetcutiMD
Cardiology • Ann Arbor, MIAdult Congenital Heart Disease, Interventional Cardiology
Professor, Internal Medicine, University of Michigan Medical School
Dr. Chetcuti is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1500 E Medical Center Dr
3rd Floor Cardiovascular Center
Ann Arbor, MI 48109Phone+1 888-287-1082- Is this information wrong?
Summary
- Dr. Stanley Chetcuti is a cardiologist in Ann Arbor, MI and is affiliated with multiple hospitals in the area, including Veterans Affairs Ann Arbor Healthcare System and Michigan Medicine. He received his medical degree from University of Malta School of Medicine and has been in practice 27 years. He specializes in structural heart disease and interventional cardiology and is experienced in general cardiology, cardiac catheterization, percutaneous coronary intervention, peripheral vascular disease, and cardiac critical care.
Education & Training
Cleveland Clinic FoundationFellowship, Cardiovascular Disease, 1995 - 1998
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1992 - 1995
University of Malta School of MedicineClass of 1990
Certifications & Licensure
MI State Medical License 1999 - 2024
MN State Medical License 1994 - 1996- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in High Risk and Very High Risk Subjects Who Need Aortic Valve Replacement Start of enrollment: 2010 Dec 10
- Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI). Start of enrollment: 2012 Apr 01
- Safety & Efficacy Study of the Medtronic CoreValve® System-Treatment of Symptomatic Severe Aortic Stenosis With Significant Comorbidities in Extreme Risk Subjects Who Need Aortic Valve Replacement Start of enrollment: 2012 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- Use and performance of the evolut FX transcatheter aortic valve system.Tanvir Bajwa, Guilherme F Attizzani, Hemal Gada, Stanley J Chetcuti, Mathew R Williams, Mustafa Ahmed, George A Petrossian, Matthew D Saybolt, Suhail Q Allaqaband, Wil...> ;Cardiovascular Revascularization Medicine. 2024 Apr 7
- Transcatheter aortic valve implantation in patients with high-risk symptomatic native aortic regurgitation (ALIGN-AR): a prospective, multicentre, single-arm study.Torsten P Vahl, Vinod H Thourani, Raj R Makkar, Nadira Hamid, Omar K Khalique, David Daniels, James M McCabe, Lowell Satler, Mark Russo, Wen Cheng, Isaac George, Gabri...> ;Lancet. 2024 Apr 13
- 1 citationsReinterventions After CoreValve/Evolut Transcatheter or Surgical Aortic Valve Replacement for Treatment of Severe Aortic Stenosis.Daniel O'Hair, Paul Mahoney, Nicolas M Van Mieghem, Stephan Windecker, Mathew R Williams, Andrew D Althouse, Kendra J Grubb, John C Lisko, William Merhi, John K Forres...> ;JACC. Cardiovascular Interventions. 2024 Mar 7
- Join now to see all
Journal Articles
- Transcatheter Aortic Valve Replacement in Low-Risk Patients with Bicuspid Aortic Valve StenosisJohn K Forrest, Basel Ramlawi, Neal S Kleiman, Stanley J Chetcuti, Hector I Michelena, Abeel A Mangi, Jeffrey A Skiles, Jeffrey J Popma, Michael J Reardon, JAMA Cardiology
- Original Research Self-Expanding Transcatheter Aortic Valve Replacement in Patients with Low-Gradient Aortic StenosisHarold L Dauerman, Jon R Resar, Steven J Yakubov, P Michael Grossman, Stanley J Chetcuti, G Michael Deeb, Jeffrey J Popma, Jae K Oh, ScienceDirect
Lectures
- 3 Illustrative Cases (Optimal Valve Sizing, Reducing New Pacemakers, and Coronary Access Issues) – A Case-Based DiscussionCRF Transcatheter Valve Therapy (TVT) - Structural Heart Disease Summit - Chicago, IL - 6/13/2019
- Enabling Early TAVR Patient Ambulation Outside the ICU With the Tempo LeadCRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/26/2019
- Making the Case for… - Anatomic Considerations and Optimizing Procedural Outcomes With Case PresentationsCRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/26/2019
Press Mentions
BioTrace Medical Announces Key Events Featuring Tempo Temporary Pacing Lead at TCT 2019September 19th, 2019
Interventional Cardiologist @umichCVC: Low-Risk Approval for #TAVR Is a "Momentous Event" That's "Completely Transformed the Way We Treat People with Aortic Stenosis"August 16th, 2019
BioTrace Medical Announces Key Events Featuring Tempo Temporary Pacing Lead at TVT 2019June 5th, 2019- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
Veterans Affairs Ann Arbor Healthcare SystemAnn Arbor, Michigan
University of Michigan Medical CenterAnn Arbor, Michigan
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
